Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Assessing Restoration Effects on River Hydromorphology Using the Process-based Morphological Quality Index in Eight European River Reaches.

Belletti B, Nardi L, Rinaldi M, Poppe M, Brabec K, Bussettini M, Comiti F, Gielczewski M, Golfieri B, Hellsten S, Kail J, Marchese E, Marcinkowski P, Okruszko T, Paillex A, Schirmer M, Stelmaszczyk M, Surian N.

Environ Manage. 2018 Jan;61(1):69-84. doi: 10.1007/s00267-017-0961-x. Epub 2017 Nov 17.

PMID:
29150720
2.

CDK6 protects epithelial ovarian cancer from platinum-induced death via FOXO3 regulation.

Dall'Acqua A, Sonego M, Pellizzari I, Pellarin I, Canzonieri V, D'Andrea S, Benevol S, Sorio R, Giorda G, Califano D, Bagnoli M, Militello L, Mezzanzanica D, Chiappetta G, Armenia J, Belletti B, Schiappacassi M, Baldassarre G.

EMBO Mol Med. 2017 Oct;9(10):1415-1433. doi: 10.15252/emmm.201607012.

3.

Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells.

Sonego M, Pellizzari I, Dall'Acqua A, Pivetta E, Lorenzon I, Benevol S, Bomben R, Spessotto P, Sorio R, Gattei V, Belletti B, Schiappacassi M, Baldassarre G.

Sci Rep. 2017 Aug 2;7(1):7104. doi: 10.1038/s41598-017-07005-1.

4.

Loss of p27kip1 increases genomic instability and induces radio-resistance in luminal breast cancer cells.

Berton S, Cusan M, Segatto I, Citron F, D'Andrea S, Benevol S, Avanzo M, Dall'Acqua A, Schiappacassi M, Bristow RG, Belletti B, Baldassarre G.

Sci Rep. 2017 Apr 4;7(1):595. doi: 10.1038/s41598-017-00734-3.

5.

p27kip1: An all-round tumor suppressor.

Belletti B, Fabris L, Baldassarre G.

Mol Cell Oncol. 2016 Feb 18;3(5):e1141742. doi: 10.1080/23723556.2016.1141742. eCollection 2016.

6.

An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma.

Citron F, Armenia J, Franchin G, Polesel J, Talamini R, D'Andrea S, Sulfaro S, Croce CM, Klement W, Otasek D, Pastrello C, Tokar T, Jurisica I, French D, Bomben R, Vaccher E, Serraino D, Belletti B, Vecchione A, Barzan L, Baldassarre G.

Clin Cancer Res. 2017 Jul 15;23(14):3769-3780. doi: 10.1158/1078-0432.CCR-16-2814. Epub 2017 Feb 7.

7.

New tools for the hydromorphological assessment and monitoring of European streams.

Rinaldi M, Belletti B, Bussettini M, Comiti F, Golfieri B, Lastoria B, Marchese E, Nardi L, Surian N.

J Environ Manage. 2017 Nov 1;202(Pt 2):363-378. doi: 10.1016/j.jenvman.2016.11.036. Epub 2016 Nov 23.

PMID:
27889363
8.

p27kip1 expression limits H-Ras-driven transformation and tumorigenesis by both canonical and non-canonical mechanisms.

Pellizzari I, Fabris L, Berton S, Segatto I, Citron F, D'Andrea S, Cusan M, Benevol S, Perin T, Massarut S, Canzonieri V, Schiappacassi M, Belletti B, Baldassarre G.

Oncotarget. 2016 Oct 4;7(40):64560-64574. doi: 10.18632/oncotarget.11656.

9.

Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib.

Tilio M, Gambini V, Wang J, Garulli C, Kalogris C, Andreani C, Bartolacci C, Elexpuru Zabaleta M, Pietrella L, Hysi A, Iezzi M, Belletti B, Orlando F, Provinciali M, Galeazzi R, Marchini C, Amici A.

Cancer Lett. 2016 Oct 10;381(1):76-84. doi: 10.1016/j.canlet.2016.07.028. Epub 2016 Jul 27.

PMID:
27475932
10.

Preclinical validation of a novel compound targeting p70S6 kinase in breast cancer.

Segatto I, Massarut S, Boyle R, Baldassarre G, Walker D, Belletti B.

Aging (Albany NY). 2016 May;8(5):958-76. doi: 10.18632/aging.100954.

11.

Molecular biology of breast tumors and prognosis.

Baldassarre G, Belletti B.

F1000Res. 2016 Apr 21;5. pii: F1000 Faculty Rev-711. doi: 10.12688/f1000research.8158.1. eCollection 2016. Review.

12.

Meet me in the cytoplasm: A role for p27(Kip1) in the control of H-Ras.

Baldassarre G, Belletti B.

Small GTPases. 2016 Apr 2;7(2):71-5. doi: 10.1080/21541248.2016.1171279. Epub 2016 Apr 8. Review.

13.

Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway.

Fabris L, Berton S, Citron F, D'Andrea S, Segatto I, Nicoloso MS, Massarut S, Armenia J, Zafarana G, Rossi S, Ivan C, Perin T, Vaidya JS, Avanzo M, Roncadin M, Schiappacassi M, Bristow RG, Calin G, Baldassarre G, Belletti B.

Oncogene. 2016 Sep 15;35(37):4914-26. doi: 10.1038/onc.2016.23. Epub 2016 Feb 15.

14.

p27kip1 controls H-Ras/MAPK activation and cell cycle entry via modulation of MT stability.

Fabris L, Berton S, Pellizzari I, Segatto I, D'Andrea S, Armenia J, Bomben R, Schiappacassi M, Gattei V, Philips MR, Vecchione A, Belletti B, Baldassarre G.

Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):13916-21. doi: 10.1073/pnas.1508514112. Epub 2015 Oct 28.

15.

SUMOylation regulates p27Kip1 stability and localization in response to TGFβ.

Lovisa S, Citro S, Sonego M, Dall'Acqua A, Ranzuglia V, Berton S, Colombatti A, Belletti B, Chiocca S, Schiappacassi M, Baldassarre G.

J Mol Cell Biol. 2016 Feb;8(1):17-30. doi: 10.1093/jmcb/mjv056. Epub 2015 Oct 8.

16.

Time-tuning cancer therapy.

Baldassarre G, Segatto I, Belletti B.

Aging (Albany NY). 2015 Aug;7(8):531-2. No abstract available.

PMID:
26298846
Free PMC Article
17.

Roles of CDKN1B in cancer?

Belletti B, Baldassarre G.

Aging (Albany NY). 2015 Aug;7(8):529-30. No abstract available.

18.

Genetic characterization of p27(kip1) and stathmin in controlling cell proliferation in vivo.

Berton S, Pellizzari I, Fabris L, D'Andrea S, Segatto I, Canzonieri V, Marconi D, Schiappacassi M, Benevol S, Gattei V, Colombatti A, Belletti B, Baldassarre G.

Cell Cycle. 2014;13(19):3100-11. doi: 10.4161/15384101.2014.949512.

19.

Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signaling.

Segatto I, Berton S, Sonego M, Massarut S, Perin T, Piccoli E, Colombatti A, Vecchione A, Baldassarre G, Belletti B.

Oncotarget. 2014 Aug 15;5(15):6267-79.

20.

Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition.

Kalogris C, Garulli C, Pietrella L, Gambini V, Pucciarelli S, Lucci C, Tilio M, Zabaleta ME, Bartolacci C, Andreani C, Giangrossi M, Iezzi M, Belletti B, Marchini C, Amici A.

Biochem Pharmacol. 2014 Aug 1;90(3):226-34. doi: 10.1016/j.bcp.2014.05.014. Epub 2014 May 27.

PMID:
24875448
21.

Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner.

Armenia J, Fabris L, Lovat F, Berton S, Segatto I, D'Andrea S, Ivan C, Cascione L, Calin GA, Croce CM, Colombatti A, Vecchione A, Belletti B, Baldassarre G.

Oncotarget. 2014 Mar 15;5(5):1185-97.

22.

p70S6 kinase mediates breast cancer cell survival in response to surgical wound fluid stimulation.

Segatto I, Berton S, Sonego M, Massarut S, Fabris L, Armenia J, Mileto M, Colombatti A, Vecchione A, Baldassarre G, Belletti B.

Mol Oncol. 2014 May;8(3):766-80. doi: 10.1016/j.molonc.2014.02.006. Epub 2014 Mar 12.

23.

Inhibition of breast cancer local relapse by targeting p70S6 kinase activity.

Segatto I, Berton S, Sonego M, Massarut S, D'Andrea S, Perin T, Fabris L, Armenia J, Rampioni G, Lovisa S, Schiappacassi M, Colombatti A, Bristow RG, Vecchione A, Baldassarre G, Belletti B.

J Mol Cell Biol. 2013 Dec;5(6):428-31. doi: 10.1093/jmcb/mjt027. Epub 2013 Jul 29. No abstract available.

PMID:
23899505
24.

A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis.

Vecchione A, Belletti B, Lovat F, Volinia S, Chiappetta G, Giglio S, Sonego M, Cirombella R, Onesti EC, Pellegrini P, Califano D, Pignata S, Losito S, Canzonieri V, Sorio R, Alder H, Wernicke D, Stoppacciaro A, Baldassarre G, Croce CM.

Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9845-50. doi: 10.1073/pnas.1305472110. Epub 2013 May 22.

25.

Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer.

Sonego M, Schiappacassi M, Lovisa S, Dall'Acqua A, Bagnoli M, Lovat F, Libra M, D'Andrea S, Canzonieri V, Militello L, Napoli M, Giorda G, Pivetta B, Mezzanzanica D, Barbareschi M, Valeri B, Canevari S, Colombatti A, Belletti B, Del Sal G, Baldassarre G.

EMBO Mol Med. 2013 May;5(5):707-22. doi: 10.1002/emmm.201201504. Epub 2013 Apr 22. Erratum in: EMBO Mol Med. 2014 Feb;6(2):295.

26.

Stathmin is dispensable for tumor onset in mice.

D'Andrea S, Berton S, Segatto I, Fabris L, Canzonieri V, Colombatti A, Vecchione A, Belletti B, Baldassarre G.

PLoS One. 2012;7(9):e45561. doi: 10.1371/journal.pone.0045561. Epub 2012 Sep 20.

27.

New light on p27(kip1) in breast cancer.

Belletti B, Baldassarre G.

Cell Cycle. 2012 Oct 1;11(19):3701-2. doi: 10.4161/cc.21573. Epub 2012 Aug 16. No abstract available.

28.

Stathmin: a protein with many tasks. New biomarker and potential target in cancer.

Belletti B, Baldassarre G.

Expert Opin Ther Targets. 2011 Nov;15(11):1249-66. doi: 10.1517/14728222.2011.620951. Epub 2011 Oct 7. Review.

PMID:
21978024
29.

Role of T198 modification in the regulation of p27(Kip1) protein stability and function.

Schiappacassi M, Lovisa S, Lovat F, Fabris L, Colombatti A, Belletti B, Baldassarre G.

PLoS One. 2011 Mar 14;6(3):e17673. doi: 10.1371/journal.pone.0017673.

30.

p27kip1 controls cell morphology and motility by regulating microtubule-dependent lipid raft recycling.

Belletti B, Pellizzari I, Berton S, Fabris L, Wolf K, Lovat F, Schiappacassi M, D'Andrea S, Nicoloso MS, Lovisa S, Sonego M, Defilippi P, Vecchione A, Colombatti A, Friedl P, Baldassarre G.

Mol Cell Biol. 2010 May;30(9):2229-40. doi: 10.1128/MCB.00723-09. Epub 2010 Mar 1.

31.

The tumor suppressor functions of p27(kip1) include control of the mesenchymal/amoeboid transition.

Berton S, Belletti B, Wolf K, Canzonieri V, Lovat F, Vecchione A, Colombatti A, Friedl P, Baldassarre G.

Mol Cell Biol. 2009 Sep;29(18):5031-45. doi: 10.1128/MCB.00144-09. Epub 2009 Jul 13.

32.

p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis.

Schiappacassi M, Lovat F, Canzonieri V, Belletti B, Berton S, Di Stefano D, Vecchione A, Colombatti A, Baldassarre G.

Mol Cancer Ther. 2008 May;7(5):1164-75. doi: 10.1158/1535-7163.MCT-07-2154.

33.

Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding.

Belletti B, Vaidya JS, D'Andrea S, Entschladen F, Roncadin M, Lovat F, Berton S, Perin T, Candiani E, Reccanello S, Veronesi A, Canzonieri V, Trovò MG, Zaenker KS, Colombatti A, Baldassarre G, Massarut S.

Clin Cancer Res. 2008 Mar 1;14(5):1325-32. doi: 10.1158/1078-0432.CCR-07-4453.

34.

Stathmin activity influences sarcoma cell shape, motility, and metastatic potential.

Belletti B, Nicoloso MS, Schiappacassi M, Berton S, Lovat F, Wolf K, Canzonieri V, D'Andrea S, Zucchetto A, Friedl P, Colombatti A, Baldassarre G.

Mol Biol Cell. 2008 May;19(5):2003-13. doi: 10.1091/mbc.E07-09-0894. Epub 2008 Feb 27.

35.

Fez1/Lzts1 absence impairs Cdk1/Cdc25C interaction during mitosis and predisposes mice to cancer development.

Vecchione A, Baldassarre G, Ishii H, Nicoloso MS, Belletti B, Petrocca F, Zanesi N, Fong LY, Battista S, Guarnieri D, Baffa R, Alder H, Farber JL, Donovan PJ, Croce CM.

Cancer Cell. 2007 Mar;11(3):275-89.

36.

p27(kip1) functional regulation in human cancer: a potential target for therapeutic designs.

Belletti B, Nicoloso MS, Schiappacassi M, Chimienti E, Berton S, Lovat F, Colombatti A, Baldassarre G.

Curr Med Chem. 2005;12(14):1589-605. Review.

PMID:
16022660
37.

HMGA1 protein expression sensitizes cells to cisplatin-induced cell death.

Baldassarre G, Belletti B, Battista S, Nicoloso MS, Pentimalli F, Fedele M, Croce CM, Fusco A.

Oncogene. 2005 Oct 13;24(45):6809-19.

PMID:
16007157
38.

p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion.

Baldassarre G, Belletti B, Nicoloso MS, Schiappacassi M, Vecchione A, Spessotto P, Morrione A, Canzonieri V, Colombatti A.

Cancer Cell. 2005 Jan;7(1):51-63.

39.

The transformed phenotype.

Hoff H, Belletti B, Zhang H, Sell C.

Methods Mol Biol. 2004;285:95-104. Review. No abstract available.

PMID:
15269402
40.

Linking inflammation to cell cycle progression.

Baldassarre G, Nicoloso MS, Schiappacassi M, Chimienti E, Belletti B.

Curr Pharm Des. 2004;10(14):1653-66. Review.

PMID:
15134563
41.

Critical role of cyclin D3 in TSH-dependent growth of thyrocytes and in hyperproliferative diseases of the thyroid gland.

Motti ML, Boccia A, Belletti B, Bruni P, Troncone G, Cito L, Monaco M, Chiappetta G, Baldassarre G, Palombini L, Fusco A, Viglietto G.

Oncogene. 2003 Oct 23;22(48):7576-86.

PMID:
14576819
42.

Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma.

Baldassarre G, Battista S, Belletti B, Thakur S, Pentimalli F, Trapasso F, Fedele M, Pierantoni G, Croce CM, Fusco A.

Mol Cell Biol. 2003 Apr;23(7):2225-38.

43.

Nuclear translocation of insulin receptor substrate-1 by oncogenes and Igf-I. Effect on ribosomal RNA synthesis.

Tu X, Batta P, Innocent N, Prisco M, Casaburi I, Belletti B, Baserga R.

J Biol Chem. 2002 Nov 15;277(46):44357-65. Epub 2002 Aug 28.

44.

Regulation of Id1 protein expression in mouse embryo fibroblasts by the type 1 insulin-like growth factor receptor.

Belletti B, Drakas R, Morrione A, Tu X, Prisco M, Yuan T, Casaburi I, Baserga R.

Exp Cell Res. 2002 Jul 1;277(1):107-18.

PMID:
12061821
45.

Glial cell line-derived neurotrophic factor induces proliferative inhibition of NT2/D1 cells through RET-mediated up-regulation of the cyclin-dependent kinase inhibitor p27(kip1).

Baldassarre G, Bruni P, Boccia A, Salvatore G, Melillo RM, Motti ML, Napolitano M, Belletti B, Fusco A, Santoro M, Viglietto G.

Oncogene. 2002 Mar 7;21(11):1739-49.

46.

Regulation of Id2 gene expression by the type 1 IGF receptor and the insulin receptor substrate-1.

Navarro M, Valentinis B, Belletti B, Romano G, Reiss K, Baserga R.

Endocrinology. 2001 Dec;142(12):5149-57.

PMID:
11713209
47.

The role of the insulin receptor substrate-1 in the differentiation of rat hippocampal neuronal cells.

Morrione A, Navarro M, Romano G, Dews M, Reiss K, Valentinis B, Belletti B, Baserga R.

Oncogene. 2001 Aug 9;20(35):4842-52.

48.
49.

Efficient in vitro and in vivo gene regulation of a retrovirally delivered pro-apoptotic factor under the control of the Drosophila HSP70 promoter.

Romano G, Reiss K, Tu X, Peruzzi F, Belletti B, Wang JY, Zanocco-Marani T, Baserga R.

Gene Ther. 2001 Apr;8(8):600-7.

50.

Regulation of Id2 gene expression by the insulin-like growth factor I receptor requires signaling by phosphatidylinositol 3-kinase.

Belletti B, Prisco M, Morrione A, Valentinis B, Navarro M, Baserga R.

J Biol Chem. 2001 Apr 27;276(17):13867-74. Epub 2001 Jan 29.

Supplemental Content

Loading ...
Support Center